1. Accuracy of tablet splitting and liquid measurements: an examination of who, what and how;Abu-Geras;J. Pharm. Pharmacol.,2017
2. EMA, European Medicines Agency, 2013. Committee for Medicinal Products for Human Use (CHMP), Paediatric Committee (PDCO). Guideline on Pharmaceutical Development of Medicines for Paediatric Use, EMA (2013) EMA/CHMP/QWP/805880/2012 Rev. 2. 1 August 2013. (accessed 23 March 2018).
3. EMA, European Medicines Agency, 2017. Alkindi hydrocortisone. EMA/CHMP/817958/2017. Committee for Medicinal Products for Human Use (CHMP) http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004416/WC500240368.pdf (accessed 26th March 2018).
4. A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution;Argenti;J. Urol.,2001
5. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline;Bornstein;J. Clin. Endocrinol. Metab.,2016